These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 28231894)

  • 1. [New therapeutic developments in cystic fibrosis].
    Bui S; Macey J; Fayon M; ; Bihouée T; Burgel PR; Colomb V; Corvol H; Durieu I; Hubert D; Marguet C; Mas E; Munck A; Murris-Espin M; Reix P; Sermet-Gaudelus I
    Arch Pediatr; 2016 Dec; 23(12S):12S47-12S53. PubMed ID: 28231894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CFTR genotype and clinical outcomes of adult patients carried as cystic fibrosis disease.
    Bonadia LC; de Lima Marson FA; Ribeiro JD; Paschoal IA; Pereira MC; Ribeiro AF; Bertuzzo CS
    Gene; 2014 May; 540(2):183-90. PubMed ID: 24583165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetics of Cystic Fibrosis: Clinical Implications.
    Egan ME
    Clin Chest Med; 2016 Mar; 37(1):9-16. PubMed ID: 26857764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vector-specific complementation profiles of two independent primary defects in cystic fibrosis airways.
    Zhang Y; Jiang Q; Dudus L; Yankaskas JR; Engelhardt JF
    Hum Gene Ther; 1998 Mar; 9(5):635-48. PubMed ID: 9551612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of delta F508 cystic fibrosis transmembrane conductance regulator protein and related chloride transport properties in the gallbladder epithelium from cystic fibrosis patients.
    Dray-Charier N; Paul A; Scoazec JY; Veissière D; Mergey M; Capeau J; Soubrane O; Housset C
    Hepatology; 1999 Jun; 29(6):1624-34. PubMed ID: 10347100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cystic fibrosis: molecular update and clinical implications].
    Orozco L; Chávez M; Saldaña Y; Velázquez R; Carnevale A; González-del Angel A; Jiménez S
    Rev Invest Clin; 2006; 58(2):139-52. PubMed ID: 16827266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cystic fibrosis transmembrane conductance regulator (CFTR) and renal function.
    Stanton BA
    Wien Klin Wochenschr; 1997 Jun; 109(12-13):457-64. PubMed ID: 9261986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [From the laboratory to the clinic: CFTR and the therapeutic options for cystic fibrosis].
    Mayol J; Alvarez de Arcaya Vicente A; Arbeo Escolar AM; Peña Soria MJ; Alvarez Fernández-Represa J
    An Med Interna; 2000 Feb; 17(2):92-8. PubMed ID: 10829466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of a cAMP-stimulated chloride secretion in regenerating poorly differentiated airway epithelial cells by adenovirus-mediated CFTR gene transfer.
    Dupuit F; Chinet T; Zahm JM; Pierrot D; Hinnrasky J; Kaplan H; Bonnet N; Puchelle E
    Hum Gene Ther; 1997 Aug; 8(12):1439-50. PubMed ID: 9287144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [CFTR and transepithelial ionic transport abnormalities in cystic fibrosis].
    Becq F
    Arch Pediatr; 2003 Sep; 10 Suppl 2():325s-332s. PubMed ID: 14671929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective activation of cystic fibrosis transmembrane conductance regulator Cl- and HCO3- conductances.
    Reddy MM; Quinton PM
    JOP; 2001 Jul; 2(4 Suppl):212-8. PubMed ID: 11875262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cystic fibrosis transmembrane conductance regulator (CFTR)-mediated residual chloride secretion does not protect against early chronic Pseudomonas aeruginosa infection in F508del homozygous cystic fibrosis patients.
    Derichs N; Mekus F; Bronsveld I; Bijman J; Veeze HJ; von der Hardt H; Tummler B; Ballmann M
    Pediatr Res; 2004 Jan; 55(1):69-75. PubMed ID: 14605249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New treatments targeting the basic defects in cystic fibrosis.
    Fajac I; Wainwright CE
    Presse Med; 2017 Jun; 46(6 Pt 2):e165-e175. PubMed ID: 28554723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Active intestinal chloride secretion in human carriers of cystic fibrosis mutations: an evaluation of the hypothesis that heterozygotes have subnormal active intestinal chloride secretion.
    Högenauer C; Santa Ana CA; Porter JL; Millard M; Gelfand A; Rosenblatt RL; Prestidge CB; Fordtran JS
    Am J Hum Genet; 2000 Dec; 67(6):1422-7. PubMed ID: 11055897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Episomal expression of wild-type CFTR corrects cAMP-dependent chloride transport in respiratory epithelial cells.
    Lei DC; Kunzelmann K; Koslowsky T; Yezzi MJ; Escobar LC; Xu Z; Ellison AR; Rommens JM; Tsui L-C ; Tykocinski M; Gruenert DC
    Gene Ther; 1996 May; 3(5):427-36. PubMed ID: 9156804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenovirus 5-fiber 35 chimeric vector mediates efficient apical correction of the cystic fibrosis transmembrane conductance regulator defect in cystic fibrosis primary airway epithelia.
    Granio O; Ashbourne Excoffon KJ; Henning P; Melin P; Norez C; Gonzalez G; Karp PH; Magnusson MK; Habib N; Lindholm L; Becq F; Boulanger P; Zabner J; Hong SS
    Hum Gene Ther; 2010 Mar; 21(3):251-69. PubMed ID: 19788389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cystic fibrosis transmembrane conductance regulator intracellular processing, trafficking, and opportunities for mutation-specific treatment.
    Rogan MP; Stoltz DA; Hornick DB
    Chest; 2011 Jun; 139(6):1480-1490. PubMed ID: 21652558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cystic fibrosis transmembrane conductance regulator gene and ion channel function in patients with idiopathic pancreatitis.
    Bishop MD; Freedman SD; Zielenski J; Ahmed N; Dupuis A; Martin S; Ellis L; Shea J; Hopper I; Corey M; Kortan P; Haber G; Ross C; Tzountzouris J; Steele L; Ray PN; Tsui LC; Durie PR
    Hum Genet; 2005 Dec; 118(3-4):372-81. PubMed ID: 16193325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repairing the basic defect in cystic fibrosis - one approach is not enough.
    Farinha CM; Matos P
    FEBS J; 2016 Jan; 283(2):246-64. PubMed ID: 26416076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Functional characterization of naturally occurring CFTR mutants: interest for cystic fibrosis].
    Romey MC
    Ann Biol Clin (Paris); 2006; 64(5):429-37. PubMed ID: 17040873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.